Chandelier
Senior Member (Voting Rights)
Heterogeneity in ME/CFS
Last week, in a posting on X, the Simmaron Research Centre, USA (whose institute works to advance translational science in treating neuroimmune diseases) have highlighted that "one of the biggest challenges in ME/CFS research has been patient heterogeneity". This research group is behind a...
www.meresearch.org.uk
Heterogeneity in ME/CFS
Conclusion
ME/CFS research is complicated because the diagnosis brings together people who share core features but may differ in factors such as disease severity, symptom patterns, triggers, co-existing conditions and underlying biology.
Combining all those with the disease together and assuming they are identical can blur research findings.
Treating heterogeneity with curiosity may help researchers identify subgroups, discover more reliable biomarkers, and eventually develop treatments that are better matched to individuals with ME/CFS.
